FDA
label_change
· 2021-03-25
FDA Approved: MYRBETRIQ — Supplemental Application (Astellas Pharma US, Inc.)
Summary
FDA has approved a supplemental application for MYRBETRIQ (mirabegron) from Astellas US, resulting in changes to the product labeling. The action may include ex…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MYRBETRIQ (MIRABEGRON)